>
>
Microbiome Diagnostics Market – By Product (Kits and Reagents, Instruments), Technology (16S rRNA Sequencing, Shotgun Metagenomics), Sample (Fecal Samples, Saliva Samples), Application (Disease diagnostic), End-use – Global Forecast (2024 – 2032)
Download Free PDF
Microbiome Diagnostics Market
Get a free sample of this reportGet a free sample of this report Microbiome Diagnostics Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 10
Tables & Figures: 347
Countries covered: 22
Pages: 250
Download Free PDF
Microbiome Diagnostics Market Size
Microbiome Diagnostics Market size was valued at around USD 143.1 million in 2023 and is estimated to grow at 13.4% CAGR from 2024 to 2032. Microbiome diagnostics refers to the application of advanced technologies and analytical methods to characterize and analyze the composition, diversity, and functional attributes of microbial communities residing within the human body, environmental samples, or other habitats.
It encompasses the identification, quantification, and profiling of microorganisms including bacteria, archaea, viruses, fungi, and other microbes using techniques such as next-generation sequencing, metagenomics, metatranscriptomics, metabolomics, and bioinformatics analysis. The increasing prevalence of chronic disease diseases includes cardiovascular diseases, diabetes, and cancer serves as a substantial impetus for market growth. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths from cancer worldwide. Thus, the advancement and widespread adoption of microbiome diagnostics are essential for enhancing the diagnosis, treatment management, and risk prediction of cancer.
Furthermore, rising demand of personalized medicine, growing awareness about importance of human microbiomes, and rising funding & investments in microbiome research are the contributing factors stimulating the market growth.
Microbiome Diagnostics Market Trends
Microbiome research has risen to prominence drawing substantial investment due to its wide-ranging effects on human health, environmental equilibrium, and agricultural productivity. Comprising myriad microorganisms inhabiting diverse bodily niches, the human microbiome, stands pivotal in maintaining holistic wellness and internal balance. Concurrently, the progression of sequencing technologies, advances in bioinformatics analysis, and interdisciplinary collaborations have propelled a surge in global microbiome research initiatives.
Microbiome Diagnostics Market Analysis
Based on product, the market is divided into kits & reagents, and instruments. The kits and reagents segment is estimated to account for USD 296.6 million by the end of 2032.
Based on technology, the microbiome diagnostics market is bifurcated into 16S rRNA sequencing, shotgun metagenomics, metatranscriptomics, and other technologies. The 16S rRNA sequencing segment accounted for USD 76.5 million in 2023.
Based on sample, the microbiome diagnostics market is segmented into fecal samples, saliva samples, skin samples, and other samples. The fecal samples segment is estimated to account for USD 166.3 million revenue by the end of 2032.
Based on application, the microbiome diagnostics market is bifurcated into disease diagnostic and research applications. The disease diagnostic is further bifurcated into gastrointestinal disorders, metabolic disorders, and other disease diagnostics. The disease diagnostic segment accounted for USD 81.2 million in 2023.
Based on end-use, the microbiome diagnostics market is classified into hospitals, academic and research institutes, pharmaceuticals, and biotechnology companies. The hospitals segment accounted for USD 63.9 million in 2023.
U.S. microbiome diagnostics market is anticipated to grow at CAGR of 13.1% during the analysis timeframe.
UK is anticipated to witness robust growth in the global microbiome diagnostics market.
China microbiome diagnostics market is anticipated to witness lucrative growth between 2024 – 2032.
South Korea microbiome diagnostics market is expected to grow significantly over the years.
Microbiome Diagnostics Market Share
The microbiome diagnostics industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.
Microbiome Diagnostics Market Companies
Some of the eminent market participants operating in the microbiome diagnostics industry include:
Microbiome Diagnostics Industry News:
The microbiome diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Technology
Market, By Sample
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries: